BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16844365)

  • 1. Epigenetic alchemy for cell fate conversion.
    Kondo T
    Curr Opin Genet Dev; 2006 Oct; 16(5):502-7. PubMed ID: 16844365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic control of neural stem cell fate.
    Hsieh J; Gage FH
    Curr Opin Genet Dev; 2004 Oct; 14(5):461-9. PubMed ID: 15380235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells.
    Balasubramaniyan V; Boddeke E; Bakels R; Küst B; Kooistra S; Veneman A; Copray S
    Neuroscience; 2006 Dec; 143(4):939-51. PubMed ID: 17084985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of self-renewal and fate determination in neural stem cells.
    Mohamed Ariff I; Mitra A; Basu A
    J Neurosci Res; 2012 Mar; 90(3):529-39. PubMed ID: 22183977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epigenetic regulation involved in fate specification of neural cells].
    Sanosaka T; Tsujimura K; Nakashima K
    Tanpakushitsu Kakusan Koso; 2008 Mar; 53(4 Suppl):331-7. PubMed ID: 21089300
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells.
    Sharma R; Ottenhof T; Rzeczkowska PA; Niles LP
    J Pineal Res; 2008 Oct; 45(3):277-84. PubMed ID: 18373554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin remodeling in neural development and plasticity.
    Hsieh J; Gage FH
    Curr Opin Cell Biol; 2005 Dec; 17(6):664-71. PubMed ID: 16226449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of cardiovascular differentiation.
    Ohtani K; Dimmeler S
    Cardiovasc Res; 2011 Jun; 90(3):404-12. PubMed ID: 21372004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development.
    Ikegami K; Ohgane J; Tanaka S; Yagi S; Shiota K
    Int J Dev Biol; 2009; 53(2-3):203-14. PubMed ID: 19412882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gcm/Glide-dependent conversion into glia depends on neural stem cell age, but not on division, triggering a chromatin signature that is conserved in vertebrate glia.
    Flici H; Erkosar B; Komonyi O; Karatas OF; Laneve P; Giangrande A
    Development; 2011 Oct; 138(19):4167-78. PubMed ID: 21852399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation in neural stem cell differentiation.
    Juliandi B; Abematsu M; Nakashima K
    Dev Growth Differ; 2010 Aug; 52(6):493-504. PubMed ID: 20608952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic control.
    Delcuve GP; Rastegar M; Davie JR
    J Cell Physiol; 2009 May; 219(2):243-50. PubMed ID: 19127539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin remodeling in embryonic stem cells: regulating the balance between pluripotency and differentiation.
    Keenen B; de la Serna IL
    J Cell Physiol; 2009 Apr; 219(1):1-7. PubMed ID: 19097034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation and histone acetylation patterns in cultured bovine fibroblasts for nuclear transfer.
    Giraldo AM; Lynn JW; Purpera MN; Godke RA; Bondioli KR
    Mol Reprod Dev; 2007 Dec; 74(12):1514-24. PubMed ID: 17440941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation in cell reprogramming revealed by genome-wide analysis.
    Hong CP; Park J; Roh TY
    Epigenomics; 2011 Feb; 3(1):73-81. PubMed ID: 22126154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic reprogramming: enforcer or enabler of developmental fate?
    Combes AN; Whitelaw E
    Dev Growth Differ; 2010 Aug; 52(6):483-91. PubMed ID: 20608951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin proteomics and epigenetic regulatory circuits.
    Bönisch C; Nieratschker SM; Orfanos NK; Hake SB
    Expert Rev Proteomics; 2008 Feb; 5(1):105-19. PubMed ID: 18282127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.